Literature DB >> 21988640

Measuring psychological well-being in South Asians with diabetes; a qualitative investigation of the PHQ-9 and the WHO-5 as potential screening tools for measuring symptoms of depression.

C E Lloyd1, T Roy, S Begum, S Mughal, A H Barnett.   

Abstract

BACKGROUND: People from South Asian backgrounds living in the UK have a greatly increased risk of developing Type 2 diabetes. Whether or not this patient group also experience high rates of depressive symptoms (known to be the case in Caucasian populations with diabetes) remains unknown, partly because it is unclear whether the screening tools used are culturally relevant. The aim of this study was to develop culturally competent translations (in both written and audio formats) of two screening tools used to measure symptoms of depression in languages with no written form and establish their face validity.
METHODS: Adults with Type 2 diabetes from two South Asian minority ethnic groups (from Bangladesh and Pakistan) whose main language is only spoken (Sylheti and Mirpuri) were recruited via the Birmingham Heartlands Hospital Diabetes Centre. Participants attended two focus group meetings to consider the content and method of delivery of two questionnaires measuring symptoms of depression, the Patient Health Questionnaire (PHQ-9) and the World Health Organization Well-being Index (WHO-5).
RESULTS: Culturally equivalent content was achieved for both questionnaires in both languages. The Mirpuri men and women groups did not indicate a clear preference for either mode of questionnaire delivery; however, the Sylheti groups' preference was for independent audio-delivery in their spoken language.
CONCLUSIONS: The face validity of the PHQ-9 and the WHO-5 was established for Sylheti and Mirpuri in an audio delivery format. Psychometric testing is now needed among minority ethnic populations so that the feasibility of wider use can be determined.
© 2011 The Authors. Diabetic Medicine © 2011 Diabetes UK.

Entities:  

Mesh:

Year:  2012        PMID: 21988640     DOI: 10.1111/j.1464-5491.2011.03481.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  10 in total

1.  Effectiveness of acceptance and commitment therapy (ACT) on depression and sleep quality in painful diabetic neuropathy: a randomized clinical trial.

Authors:  Mohammadreza Davoudi; Amir Abbas Taheri; Ali Akbar Foroughi; Seyed Mojtaba Ahmadi; Khatereh Heshmati
Journal:  J Diabetes Metab Disord       Date:  2020-08-09

2.  Prevalence and influencing factors of co-morbid depression in patients with type 2 diabetes mellitus: a General Hospital based study.

Authors:  Weijun Zhang; Huiwen Xu; Shuliang Zhao; Shinan Yin; Xiaohua Wang; Jing Guo; Shengfa Zhang; Huixuan Zhou; Fugang Wang; Linni Gu; Lei Zhu; Haibo Yu; Zhiyong Qu; Donghua Tian
Journal:  Diabetol Metab Syndr       Date:  2015-06-30       Impact factor: 3.320

3.  Depression screening in HIV-positive Tanzanian adults: comparing the PHQ-2, PHQ-9 and WHO-5 questionnaires.

Authors:  C P Nolan; P J M O'Donnell; B M Desderius; M Mzombwe; M L McNairy; R N Peck; J R Kingery
Journal:  Glob Ment Health (Camb)       Date:  2018-11-19

4.  Associations between lifestyle behaviour changes and the optimal well-being of middle-aged Japanese individuals.

Authors:  Toshihiro Takao; Naoki Sumi; Yoshiyuki Yamanaka; Sohachi Fujimoto; Tomoari Kamada
Journal:  Biopsychosoc Med       Date:  2021-04-01

5.  Prevalence and Associated Factors of Diabetes Distress, Depression and Anxiety Among Primary Care Patients With Type 2 Diabetes During the COVID-19 Pandemic in Egypt: A Cross-Sectional Study.

Authors:  Hazem A Sayed Ahmed; Ahmed Mahmoud Fouad; Sally Fawzy Elotla; Anwar I Joudeh; Mona Mostafa; Asghar Shah; Jaffer Shah; Samar F Mohamed
Journal:  Front Psychiatry       Date:  2022-06-03       Impact factor: 5.435

6.  Prevalence of co-morbid depression in out-patients with type 2 diabetes mellitus in Bangladesh.

Authors:  Tapash Roy; Cathy E Lloyd; Masuma Parvin; Khondker Galib B Mohiuddin; Mosiur Rahman
Journal:  BMC Psychiatry       Date:  2012-08-22       Impact factor: 3.630

7.  A randomised wait-list controlled clinical trial of the effects of acceptance and commitment therapy in patients with type 1 diabetes: a study protocol.

Authors:  Anna Lindholm-Olinder; Johan Fischier; Jenny Fries; Sven Alfonsson; Veronika Elvingson; Jan W Eriksson; Janeth Leksell
Journal:  BMC Nurs       Date:  2015-11-19

8.  How do people of South Asian origin understand and experience depression? A protocol for a systematic review of qualitative literature.

Authors:  Roisin Mooney; Daksha Trivedi; Shivani Sharma
Journal:  BMJ Open       Date:  2016-08-30       Impact factor: 2.692

9.  Measurement properties of depression questionnaires in patients with diabetes: a systematic review.

Authors:  Susan E M van Dijk; Marcel C Adriaanse; Lennart van der Zwaan; Judith E Bosmans; Harm W J van Marwijk; Maurits W van Tulder; Caroline B Terwee
Journal:  Qual Life Res       Date:  2018-02-02       Impact factor: 4.147

10.  People with diabetes need a lower cut-off than others for depression screening with PHQ-9.

Authors:  Ewelina Cichoń; Andrzej Kiejna; Andrzej Kokoszka; Tomasz M Gondek; Rafał Radzio; Adam Jastrzębski; Beata E Andrzejewska; Fahad D Alosaimi; Cathy E Lloyd; Norman Sartorius
Journal:  PLoS One       Date:  2020-10-23       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.